Trials / Conditions / Unresectable Stage III Non-small-cell Lung Cancer

Unresectable Stage III Non-small-cell Lung Cancer

5 registered clinical trials studyying Unresectable Stage III Non-small-cell Lung Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	IBI363 (PD-1/IL-2α-bias) in Combination With Chemotherapy as Neoadjuvant Therapy in Initially Unresectable Sta NCT07408635	Shanghai Pulmonary Hospital, Shanghai, China	Phase 2
Not Yet Recruiting	Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung C NCT06591910	Shanghai Pulmonary Hospital, Shanghai, China	—
Unknown	Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer NCT04670445	Massachusetts General Hospital	N/A
Unknown	A Study of Sequential Anlotinib Followed by EP Regimen Plus Concurrent Radiotherapy for Unresectable Stage III NCT04111913	Nanfang Hospital, Southern Medical University	Phase 2
Unknown	Hypofractionated vs. Conventionally Fractionated Concurrent CRT for Unresectable Stage III NSCLC NCT03331575	Shanghai Chest Hospital	Phase 3